Selective labeling of IRAP by the tritiated AT receptor ligands [H]Angiotensin IV and its stable analog [H]AL-11
Autor: | Demaegdt, Heidi, Lukaszuk, Aneta, De Buyser, Evi, De Backer, Jean-Paul, Szemenyei, Erzsébet, Tóth, Géza, Chakravarthy, Sridhara, Panicker, Mitradas, Michotte, Yvette, Tourwé, Dirk, Vauquelin, Georges |
---|---|
Přispěvatelé: | Department of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel (VUB), Hungarian Academy of Sciences (MTA), Departement of Neurobiology [NCBS-TIFR], National Centre for Biological Sciences [TIFR] (NCBS), Tata Institute for Fundamental Research (TIFR)-Tata Institute for Fundamental Research (TIFR), Department of Pharmaceutical Chemistry, Research group of Experimental Pharmacology |
Jazyk: | angličtina |
Rok vydání: | 2009 |
Předmět: | |
Zdroj: | Molecular and Cellular Endocrinology Molecular and Cellular Endocrinology, Elsevier, 2009, 311 (1-2), pp.77. ⟨10.1016/j.mce.2009.07.020⟩ |
ISSN: | 0303-7207 |
DOI: | 10.1016/j.mce.2009.07.020⟩ |
Popis: | International audience; ‘AT receptors' through which angiotensin IV (Ang IV) improves memory acquisition, were recently identified as insulin regulated aminopeptidase (IRAP). Radioligand binding studies have hitherto been performed with iodinated Ang IV in the presence of divalent cation chelators EDTA and 1,10-phenanthrolin. Hence, they referred to the apo-form of IRAP. Presently, binding of [H]Ang IV and [H]AL-11, a stable Ang IV analog, was compared on Chinese hamster ovary (CHO-K1) and mouse hippocampal (P40H1) cell membranes. With chelators, their high affinity sites showed the same pharmacological profile as for [I]Ang IV binding. Without chelators, only high affinity binding was perceived for [H]AL-11. The same pharmacological profile was recorded in both membrane preparations; it was different from the one in presence of chelators and corresponded to catalytically active IRAP (despite the concurrent presence aminopeptidase N (APN) in P40H1 cell membranes). This confirms that the active and apo-forms of IRAP have a distinct pharmacological profile. |
Databáze: | OpenAIRE |
Externí odkaz: |